Transnational Strategies and Policy Papers related to Personalised Medicine

This page provides a curated overview of transnational initiatives, strategies, roadmaps, declarations and policy papers relevant to personalised medicine. It includes European and international sources that address areas such as genomic data infrastructures, personalised prevention, rare diseases, health-system transformation, cross-border collaboration, research and innovation programming, ethical and legal issues, data standards and implementation roadmaps.

These sources provide important context for understanding how personalised medicine is being coordinated beyond individual countries or regions. They can help identify shared priorities, common implementation challenges, opportunities for alignment and areas where national or regional strategies may connect to wider European or international efforts.

The list is intended as a living resource and will be updated as further initiatives, strategies and policy papers are identified.

Disclaimer

This list was prepared with the support of artificial intelligence (AI) tools and a subsequential human review and curation. Translations and extracts were AI-generated and edited for clarity, but in some cases they could not be fully verified in the original language of the legal source. Users should therefore consult the original source before relying on a summary for formal citation or detailed policy analysis.

The list is a living resource. If you are aware of a missing transnational strategy, roadmap, declaration or policy paper relevant to personalised medicine, please contact EP PerMed at eppermed@dlr.de.

Sources from Transnational Initatives